| abstract |
A compound or a salt thereof having the following structure is provided: For the treatment or reduction of androgen-dependent diseases such as prostate cancer, benign prostatic hyperplasia, polycystic ovary syndrome, acne, hirsutism, seborrheic dermatitis, androgenetic alopecia, alopecia areata, muscle wasting and weakness, Sarcopenia, hypogonadism, erectile dysfunction, female sexual dysfunction, and osteoporosis. It can be formulated with a pharmaceutically acceptable diluent or carrier, or manufactured into any pharmaceutical form. Compositions with other active pharmaceutical agents are also disclosed. |